Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Guselkumab-induced vitiligo in...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Guselkumab-induced vitiligo in a patient with psoriatic arthritis

Guselkumab-induced vitiligo in a patient with psoriatic arthritis

Bibliographic Details
Main Authors: Fabrizio Martora, MD, Maria Carmela Annunziata, MD, Luigi Guerriero, MD, Teresa Battista, MD, Luca Potestio, MD, Matteo Megna, MD
Format: Article
Language:English
Published: Elsevier 2023-11-01
Series:JAAD Case Reports
Subjects:
guselkumab
psoriatic arthritis
vitiligo
Online Access:http://www.sciencedirect.com/science/article/pii/S2352512623003405
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.sciencedirect.com/science/article/pii/S2352512623003405

Similar Items

  • The use of guselkumab in psoriatic arthritis: evidence from real clinical practice
    by: N. V. Nekrasova, et al.
    Published: (2021-12-01)
  • The Evaluation of Effectiveness and Safety of Guselkumab in Patients with Psoriatic Arthritis in a Prospective Multicentre “Real-Life” Cohort Study
    by: Piero Ruscitti, et al.
    Published: (2024-03-01)
  • Guselkumab in Biologic-Naïve Patients with Active Psoriatic Arthritis in Russia: A Post Hoc Analysis of the DISCOVER-1 and -2 Randomized Clinical Trials
    by: Philip Mease, et al.
    Published: (2024-09-01)
  • Paradoxical psoriatic arthritis flare with the initiation of brodalumab and guselkumab
    by: Reem Kashlan, MPH, et al.
    Published: (2021-04-01)
  • Efficacy of Guselkumab on Axial-Related Symptoms Through up to 2 Years in Adults with Active Psoriatic Arthritis in the Phase 3, Randomized, Placebo-Controlled DISCOVER-2 Study
    by: Philip J. Mease, et al.
    Published: (2023-10-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs